17 alpha-hydroxyprogesterone caproate has been researched along with Diabetes, Gestational in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eke, AC; Graham, EM; Sheffield, J | 1 |
| Egerman, R; Istwan, N; Ramsey, R; Rhea, D; Stanziano, G | 1 |
| Gard, J; Leveno, KJ; McDonald, J; McIntire, DD; Nelson, DB; Turrichi, P | 1 |
| Catalano, PM; Mercer, BM; Schultz, BAH; Waters, TP | 1 |
| Caritis, SN; Carpenter, MW; Conway, D; Dombrowski, M; Gyamfi, C; Horton, AL; Iams, JD; Lo, J; Meis, PJ; Mercer, BM; Miodovnik, M; Momirova, V; O'Sullivan, MJ; Peaceman, AM; Ramin, SM; Rouse, DJ; Sciscione, A; Sibai, B; Spong, CY; Varner, MW | 1 |
| Dearmond, C; Henderson, ZT; How, H; Sibai, B; Wolfe, K | 1 |
1 review(s) available for 17 alpha-hydroxyprogesterone caproate and Diabetes, Gestational
| Article | Year |
|---|---|
17α-Hydroxyprogesterone Caproate and the Risk of Glucose Intolerance in Pregnancy: A Systematic Review and Meta-analysis.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Diabetes, Gestational; Female; Glucose Intolerance; Humans; Pregnancy; Premature Birth; Progestins | 2019 |
1 trial(s) available for 17 alpha-hydroxyprogesterone caproate and Diabetes, Gestational
| Article | Year |
|---|---|
The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Diabetes, Gestational; Double-Blind Method; Female; Humans; Hydroxyprogesterones; Multivariate Analysis; Pregnancy; Pregnancy, Multiple; Progestins; Risk Factors | 2009 |
4 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Diabetes, Gestational
| Article | Year |
|---|---|
Maternal characteristics influencing the development of gestational diabetes in obese women receiving 17-alpha-hydroxyprogesterone caproate.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Body Mass Index; Diabetes, Gestational; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Maternal Age; Obesity; Pregnancy; Premature Birth; Retrospective Studies; Risk Factors; Tocolytic Agents; United States | 2014 |
17-alpha Hydroxyprogesterone caproate did not reduce the rate of recurrent preterm birth in a prospective cohort study.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Cohort Studies; Diabetes, Gestational; Female; Gestational Age; Humans; Hydroxyprogesterones; Pregnancy; Premature Birth; Progestins; Prospective Studies; Recurrence; Treatment Outcome | 2017 |
Effect of 17alpha-hydroxyprogesterone caproate on glucose intolerance in pregnancy.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Diabetes, Gestational; Female; Glucose Intolerance; Humans; Hydroxyprogesterones; Pregnancy; Pregnancy Complications; Progestins | 2009 |
The rates of abnormal glucose challenge tests and gestational diabetes in women receiving 17α-hydroxyprogesterone caproate.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Blood Glucose; Diabetes, Gestational; Dose-Response Relationship, Drug; Female; Glucose Intolerance; Glucose Tolerance Test; Humans; Hydroxyprogesterones; Logistic Models; Obesity; Pregnancy; Premature Birth; Progestins; Prospective Studies; Secondary Prevention; Young Adult | 2011 |